GCLL GreenCell Incorporated (CE)

GreenCell, Inc. (OTCBB: GCLL) has recently announced the addition of Shawn Powell Joseph to the Company's Chief Financial Officer position. Ms. Powell Joseph is a doctoral scholar with a concentration in management, leadership and, information systems and technology.

GreenCell is engaged in a joint venture with SenCer Inc. to develop, commercialize and market SenCer's UltraTemp™ ceramic composite materials for home and transportation applications. GreenCell has identified multiple industries with significant commercial applications with potential revolutionary results. Some of the many applications for this technology are fuel cells, igniters, braking, oxygen sensors, and ceramic heaters.

The Company has also recently announced they have completed a fuel stack cell design utilizing their unique UltraTemp-C properties. Markets And Markets estimates global fuel cell market reached 0.14 million unit shipments in 2010 from mere 11 thousand units in 2007. During this period, shipments grew by CAGR of 132% and are further expected to rise by 115% CAGR from 2011 to 2016. The global fuel cell market which is at $650 million will be at $1.6 billion in the year 2016.

To find out more on GreenCell, Inc., please visit www.greenstocksonline.com

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid OTC Report one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. However, no representation, expressed or implied, is made as to the accuracy, completeness or correctness. In light of the above, we accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

OTC Report Email Contact